Product Recalls in Pennsylvania

Product recalls affecting Pennsylvania — including food, drugs, consumer products, medical devices, and vehicles distributed to Pennsylvania. RecallDetector monitors distribution data from the FDA, USDA, CPSC, and NHTSA to show you which recalls are relevant to your area. 2,919 recalls have been distributed to Pennsylvania in the last 12 months.

55,602 total recalls
2,919 in last 12 months

Showing 461480 of 13,473 recalls

DrugJuly 5, 2025· FDC Limited

Recalled Item: Timolol Maleate Ophthalmic Solution USP Recalled by FDC Limited Due to...

The Issue: Defective Container: spike of the cap becomes lodged in the nozzle of the...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJuly 2, 2025· Lupin Pharmaceuticals Inc.

Recalled Item: Amlodipine and Benazepril HCl Capsules USP 2.5 mg/10 mg Recalled by Lupin...

The Issue: Labeling: Incorrect or Missing Lot and/or Exp Date: released with wrong...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJune 30, 2025· Cipla USA, Inc.

Recalled Item: Budesonide Inhalation Suspension Recalled by Cipla USA, Inc. Due to Lack of...

The Issue: Lack of Assurance of Sterility: A market complaint was received for leakage...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJune 30, 2025· Dr. Reddy's Laboratories, Inc.

Recalled Item: Omeprazole Delayed-release Capsules Recalled by Dr. Reddy's Laboratories,...

The Issue: Presence of foreign tablets/capsules: presence of foreign Divalproex Sodium...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJune 30, 2025· Breckenridge Pharmaceutical, Inc.

Recalled Item: Duloxetine Delayed-Release Capsules Recalled by Breckenridge Pharmaceutical,...

The Issue: CGMP Deviations: Presence of N-nitroso-duloxetine impurity above FDA...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJune 27, 2025· Lupin Pharmaceuticals Inc.

Recalled Item: clomiPRAMINE Hydrochloride Capsules USP 25 mg Recalled by Lupin...

The Issue: Failed Impurities/Degradation Specifications: an out of specification result...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJune 27, 2025· Sandoz Inc

Recalled Item: Cefazolin for Injection Recalled by Sandoz Inc Due to Labeling: Label...

The Issue: Labeling: Label Mix-Up; cartons of Cefazolin for Injection, USP 1 gram were...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class I — Serious Health HazardOngoing
Refund
DrugJune 27, 2025· Sandoz Inc

Recalled Item: Buffered Penicillin G Potassium for Injection Recalled by Sandoz Inc Due to...

The Issue: Labeling: Label Mix-Up; Some vials of Cefazolin for Injection, USP 1 gram...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class I — Serious Health HazardOngoing
Refund
DrugJune 26, 2025· AvKARE

Recalled Item: Pitavastatin Tablets Recalled by AvKARE Due to Failed Impurity/Degradation...

The Issue: Failed Impurity/Degradation Specifications

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugJune 26, 2025· AvKARE

Recalled Item: Pitavastatin Tablets Recalled by AvKARE Due to Failed Impurity/Degradation...

The Issue: Failed Impurity/Degradation Specifications

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugJune 24, 2025· Granules Pharmaceuticals Inc.

Recalled Item: Metoprolol Succinate Extended-Release Tablets Recalled by Granules...

The Issue: Failed Dissolution Specifications: Product failed to meet dissolution...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJune 20, 2025· Lupin Pharmaceuticals Inc.

Recalled Item: Lisinopril and Hydrochlorothiazide Tablets USP 20mg/12.5mg Recalled by Lupin...

The Issue: Product Mix Up: This product is being recalled because of a complaint...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJune 20, 2025· ACCORD HEALTHCARE, INC.

Recalled Item: Levothyroxine Sodium Tablets Recalled by ACCORD HEALTHCARE, INC. Due to...

The Issue: Subpotent Drug: Assay below the approved specification

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJune 20, 2025· ACCORD HEALTHCARE, INC.

Recalled Item: Levothyroxine Sodium Tablets Recalled by ACCORD HEALTHCARE, INC. Due to...

The Issue: Subpotent Drug: Assay below the approved specification

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJune 20, 2025· ACCORD HEALTHCARE, INC.

Recalled Item: Levothyroxine Sodium Tablets Recalled by ACCORD HEALTHCARE, INC. Due to...

The Issue: Subpotent Drug: Assay below the approved specification

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJune 20, 2025· ACCORD HEALTHCARE, INC.

Recalled Item: Levothyroxine Sodium Tablets Recalled by ACCORD HEALTHCARE, INC. Due to...

The Issue: Subpotent Drug: Assay below the approved specification

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJune 20, 2025· ACCORD HEALTHCARE, INC.

Recalled Item: Levothyroxine Sodium Tablets Recalled by ACCORD HEALTHCARE, INC. Due to...

The Issue: Subpotent Drug: Assay below the approved specification

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJune 20, 2025· ACCORD HEALTHCARE, INC.

Recalled Item: Levothyroxine Sodium Tablets Recalled by ACCORD HEALTHCARE, INC. Due to...

The Issue: Subpotent Drug: Assay below the approved specification

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJune 20, 2025· ACCORD HEALTHCARE, INC.

Recalled Item: Levothyroxine Sodium Tablets Recalled by ACCORD HEALTHCARE, INC. Due to...

The Issue: Subpotent Drug: Assay below the approved specification

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJune 19, 2025· The Harvard Drug Group LLC

Recalled Item: Gabapentin Capsules Recalled by The Harvard Drug Group LLC Due to Defective...

The Issue: Defective container; blister packaging inadequately sealed.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund